跳至主要内容
临床试验/NCT02247622
NCT02247622Unknown不适用

Primary Sclerosing Cholangitis Telomere Length

Meir Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Telomere length

研究概览

简要总结

PSC is a chronic cholestatic disorder. The investigators intend to study some telomere parameters and telomere length in order to predict a premalignant state.

详细描述

Primary sclerosing cholangitis (PSC) and colitis are chronic inflammatory disorders with malignant potential. Telomerase is an enzyme complex that lengthens telomeres and has enhanced expression in numerous malignancies. In this study, we evaluated the telomerase gene copy number, telomere length, cells in senescence, aneuploidy and additional parameters of telomere dysfunction from peripheral blood lymphocytes of patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • informed consent
  • documented PSC and inflammatory bowel disease

排除标准

  • under 18 years, above 80 y
  • known active malignancy
  • decompensated cirrhosis
  • patients who cannot sign informed consent

结局指标

主要结局

Telomere length

时间窗: 1.5 years

次要结局

  • number of cells with increased telomerase RNA component (TERC) expression(1.5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ido laish

Md.

Meir Medical Center

研究点 (1)

Loading locations...

相似试验